http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 30 Jan 2026 17:15:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Jan+30/25924606.html si-local-file:///var/storage/secattach/20260130/25924606.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Jan+30/25924606.html Fri, 30 Jan 2026 17:15:00 -0500 NYXH NYXH O.07165503 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Jan+30/25924606.html si-local-file:///var/storage/secattach/20260130/25924606.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Jan+30/25924606.html Fri, 30 Jan 2026 17:15:00 -0500 NYXH NYXH O.07165503 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Jan+30/25924606.html si-local-file:///var/storage/secattach/20260130/25924606.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Jan+30/25924606.html Fri, 30 Jan 2026 17:15:00 -0500 NYXH NYXH O.07165503 http://www.streetinsider.com/Analyst+PT+Change/Nyxoah+SA+%28NYXH%29+PT+Lowered+to+%2411+at+Stifel/25912166.html Stifel analyst Jonathan Block lowered the price target on Nyxoah SA (NASDAQ: NYXH) to $11.00 (from $12.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Nyxoah+SA+%28NYXH%29+PT+Lowered+to+%2411+at+Stifel/25912166.html Thu, 29 Jan 2026 07:27:58 -0500 NYXH http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Jan+14/25849992.html si-local-file:///var/storage/secattach/20260114/25849992.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Jan+14/25849992.html Wed, 14 Jan 2026 16:05:00 -0500 NYXH NYXH O.07165503 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Jan+14/25849992.html si-local-file:///var/storage/secattach/20260114/25849992.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Jan+14/25849992.html Wed, 14 Jan 2026 16:05:00 -0500 NYXH NYXH O.07165503 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Jan+14/25849992.html si-local-file:///var/storage/secattach/20260114/25849992.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Jan+14/25849992.html Wed, 14 Jan 2026 16:05:00 -0500 NYXH NYXH O.07165503 http://www.streetinsider.com/Analyst+Comments/Nyxoah+%28NYXH%29+Reiterated+at+Buy+by+Stifel%3A++%E2%82%AC4.4MM+1Q26+Revenue+Guided/25840612.html <p>Stifel analyst Jonathan Block reiterated a Buy rating and $12.00 price target on Nyxoah SA (NASDAQ: NYXH).</p><p>The analyst commented, "For 2026, it appears Nyxoah will opt for guidance on a quarterly basis, rather than provide an annual revenue range. In 1Q26, the company is pointing to U.S. net revenue +25% q/q, or approximately €4.4MM. This is well ahead of our €2.2MME and the Street’s €2.8MME. As mentioned earlier, we believe some of the 1Q26 outperformance is likely attributable to a sell-in that is currently greater than the sell out (implant rate), although early Genio results are impressive. The stocking dynamic http://www.streetinsider.com/Analyst+Comments/Nyxoah+%28NYXH%29+Reiterated+at+Buy+by+Stifel%3A++%E2%82%AC4.4MM+1Q26+Revenue+Guided/25840612.html Tue, 13 Jan 2026 07:24:55 -0500 NYXH http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Nyxoah+SA++++++++++++++++++++++++++++++Filed+by%3A+CVI+Investments%2C+Inc./25782856.html si-local-file:///var/storage/secattach/20251229/25782856.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Nyxoah+SA++++++++++++++++++++++++++++++Filed+by%3A+CVI+Investments%2C+Inc./25782856.html Mon, 29 Dec 2025 10:04:00 -0500 NYXH NYXH O.07165503 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Nyxoah+SA++++++++++++++++++++++++++++++Filed+by%3A+CVI+Investments%2C+Inc./25782856.html si-local-file:///var/storage/secattach/20251229/25782856.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Nyxoah+SA++++++++++++++++++++++++++++++Filed+by%3A+CVI+Investments%2C+Inc./25782856.html Mon, 29 Dec 2025 10:04:00 -0500 NYXH NYXH O.07165503 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Nyxoah+SA++++++++++++++++++++++++++++++Filed+by%3A+CVI+Investments%2C+Inc./25782856.html si-local-file:///var/storage/secattach/20251229/25782856.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Nyxoah+SA++++++++++++++++++++++++++++++Filed+by%3A+CVI+Investments%2C+Inc./25782856.html Mon, 29 Dec 2025 10:04:00 -0500 NYXH NYXH O.07165503 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Dec+19/25764952.html si-local-file:///var/storage/secattach/20251219/25764952.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Dec+19/25764952.html Fri, 19 Dec 2025 16:11:00 -0500 NYXH NYXH O.07165503 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Dec+19/25764952.html si-local-file:///var/storage/secattach/20251219/25764952.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Dec+19/25764952.html Fri, 19 Dec 2025 16:11:00 -0500 NYXH NYXH O.07165503 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Dec+19/25764952.html si-local-file:///var/storage/secattach/20251219/25764952.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Dec+19/25764952.html Fri, 19 Dec 2025 16:11:00 -0500 NYXH NYXH O.07165503 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Dec+05/25706265.html si-local-file:///var/storage/secattach/20251205/25706265.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Dec+05/25706265.html Fri, 05 Dec 2025 16:05:00 -0500 NYXH NYXH O.07165503 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Dec+05/25706265.html si-local-file:///var/storage/secattach/20251205/25706265.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Dec+05/25706265.html Fri, 05 Dec 2025 16:05:00 -0500 NYXH NYXH O.07165503 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Dec+05/25706265.html si-local-file:///var/storage/secattach/20251205/25706265.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nyxoah+SA+++++++++++++++++For%3A+Dec+05/25706265.html Fri, 05 Dec 2025 16:05:00 -0500 NYXH NYXH O.07165503 http://www.streetinsider.com/Press+Releases/Nyxoah+to+Participate+in+the+Piper+Sandler+37th+Annual+Healthcare+Conference/25673171.html <p align="center"><strong>Nyxoah to Participate in the Piper Sandler 37</strong><strong>th</strong><strong> Annual Healthcare Conference</strong></p> <p align="justify"><strong>Mont-Saint-Guibert, Belgium – 27 November, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)</strong> (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the management team will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Thursday, Dec. 4, 2025. The fireside chat is scheduled at 1:30 p.m. (ET) the same day via webcast.</p> <p align="justify">A live audio webcast http://www.streetinsider.com/Press+Releases/Nyxoah+to+Participate+in+the+Piper+Sandler+37th+Annual+Healthcare+Conference/25673171.html Thu, 27 Nov 2025 16:05:00 -0500 A.32501476 NYXH NYXH O.00832386 O.07165503 http://www.streetinsider.com/Press+Releases/Nyxoah+to+Participate+in+the+Piper+Sandler+37th+Annual+Healthcare+Conference/25673171.html <p align="center"><strong>Nyxoah to Participate in the Piper Sandler 37</strong><strong>th</strong><strong> Annual Healthcare Conference</strong></p> <p align="justify"><strong>Mont-Saint-Guibert, Belgium – 27 November, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)</strong> (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the management team will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Thursday, Dec. 4, 2025. The fireside chat is scheduled at 1:30 p.m. (ET) the same day via webcast.</p> <p align="justify">A live audio webcast http://www.streetinsider.com/Press+Releases/Nyxoah+to+Participate+in+the+Piper+Sandler+37th+Annual+Healthcare+Conference/25673171.html Thu, 27 Nov 2025 16:05:00 -0500 A.32501476 NYXH NYXH O.00832386 O.07165503 http://www.streetinsider.com/Press+Releases/Nyxoah+to+Participate+in+the+Piper+Sandler+37th+Annual+Healthcare+Conference/25673171.html <p align="center"><strong>Nyxoah to Participate in the Piper Sandler 37</strong><strong>th</strong><strong> Annual Healthcare Conference</strong></p> <p align="justify"><strong>Mont-Saint-Guibert, Belgium – 27 November, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)</strong> (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the management team will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Thursday, Dec. 4, 2025. The fireside chat is scheduled at 1:30 p.m. (ET) the same day via webcast.</p> <p align="justify">A live audio webcast http://www.streetinsider.com/Press+Releases/Nyxoah+to+Participate+in+the+Piper+Sandler+37th+Annual+Healthcare+Conference/25673171.html Thu, 27 Nov 2025 16:05:00 -0500 A.32501476 NYXH NYXH O.00832386 O.07165503 http://www.streetinsider.com/Press+Releases/Nyxoah+to+Participate+in+the+Piper+Sandler+37th+Annual+Healthcare+Conference/25673171.html <p align="center"><strong>Nyxoah to Participate in the Piper Sandler 37</strong><strong>th</strong><strong> Annual Healthcare Conference</strong></p> <p align="justify"><strong>Mont-Saint-Guibert, Belgium – 27 November, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)</strong> (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the management team will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Thursday, Dec. 4, 2025. The fireside chat is scheduled at 1:30 p.m. (ET) the same day via webcast.</p> <p align="justify">A live audio webcast http://www.streetinsider.com/Press+Releases/Nyxoah+to+Participate+in+the+Piper+Sandler+37th+Annual+Healthcare+Conference/25673171.html Thu, 27 Nov 2025 16:05:00 -0500 A.32501476 NYXH NYXH O.00832386 O.07165503 http://www.streetinsider.com/Press+Releases/Nyxoah+to+Participate+in+the+Piper+Sandler+37th+Annual+Healthcare+Conference/25673171.html <p align="center"><strong>Nyxoah to Participate in the Piper Sandler 37</strong><strong>th</strong><strong> Annual Healthcare Conference</strong></p> <p align="justify"><strong>Mont-Saint-Guibert, Belgium – 27 November, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)</strong> (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the management team will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Thursday, Dec. 4, 2025. The fireside chat is scheduled at 1:30 p.m. (ET) the same day via webcast.</p> <p align="justify">A live audio webcast http://www.streetinsider.com/Press+Releases/Nyxoah+to+Participate+in+the+Piper+Sandler+37th+Annual+Healthcare+Conference/25673171.html Thu, 27 Nov 2025 16:05:00 -0500 A.32501476 NYXH NYXH O.00832386 O.07165503 http://www.streetinsider.com/Globe+Newswire/Nyxoah+to+Participate+in+the+Piper+Sandler+37th+Annual+Healthcare+Conference/25673171.html <p align="center"><strong>Nyxoah to Participate in the Piper Sandler 37</strong><strong>th</strong><strong> Annual Healthcare Conference</strong></p> <p align="justify"><strong>Mont-Saint-Guibert, Belgium – 27 November, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)</strong> (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the management team will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Thursday, Dec. 4, 2025. The fireside chat is scheduled at 1:30 p.m. (ET) the same day via webcast.</p> <p align="justify">A live audio webcast http://www.streetinsider.com/Globe+Newswire/Nyxoah+to+Participate+in+the+Piper+Sandler+37th+Annual+Healthcare+Conference/25673171.html Thu, 27 Nov 2025 16:05:00 -0500 A.32501476 NYXH NYXH O.00832386 O.07165503 http://www.streetinsider.com/Globe+Newswire/Nyxoah+to+Participate+in+the+Piper+Sandler+37th+Annual+Healthcare+Conference/25673171.html <p align="center"><strong>Nyxoah to Participate in the Piper Sandler 37</strong><strong>th</strong><strong> Annual Healthcare Conference</strong></p> <p align="justify"><strong>Mont-Saint-Guibert, Belgium – 27 November, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)</strong> (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the management team will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Thursday, Dec. 4, 2025. The fireside chat is scheduled at 1:30 p.m. (ET) the same day via webcast.</p> <p align="justify">A live audio webcast http://www.streetinsider.com/Globe+Newswire/Nyxoah+to+Participate+in+the+Piper+Sandler+37th+Annual+Healthcare+Conference/25673171.html Thu, 27 Nov 2025 16:05:00 -0500 A.32501476 NYXH NYXH O.00832386 O.07165503 http://www.streetinsider.com/Globe+Newswire/Nyxoah+to+Participate+in+the+Piper+Sandler+37th+Annual+Healthcare+Conference/25673171.html <p align="center"><strong>Nyxoah to Participate in the Piper Sandler 37</strong><strong>th</strong><strong> Annual Healthcare Conference</strong></p> <p align="justify"><strong>Mont-Saint-Guibert, Belgium – 27 November, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)</strong> (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the management team will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Thursday, Dec. 4, 2025. The fireside chat is scheduled at 1:30 p.m. (ET) the same day via webcast.</p> <p align="justify">A live audio webcast http://www.streetinsider.com/Globe+Newswire/Nyxoah+to+Participate+in+the+Piper+Sandler+37th+Annual+Healthcare+Conference/25673171.html Thu, 27 Nov 2025 16:05:00 -0500 A.32501476 NYXH NYXH O.00832386 O.07165503